Upgrade to SI Premium - Free Trial

Bausch Health Companies (BHC) PT Lowered to $25 at BMO Capital

February 21, 2019 9:35 AM
BMO Capital analyst Gary Nachman lowered the price target on Bausch Health Companies (NYSE: BHC) to $25.00 (from $26.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles